Please login to the form below

Not currently logged in
Email:
Password:

MorphoSys strengthens senior clinical development team

Appoints Gabriele Elbl, Ludger Langer and Steffen Heeger

Morphosys Dr Gabriele ElblGerman biotech company MorphoSys has expanded its senior clinical development team with three new management appointments.

Regulatory affairs head Dr Gabriele Elbl (pictured right) joins MorphoSys from Munich-based biopharmaceutical company Wilex AG, where she was senior vice president of regulatory affairs.

Prior to that she worked as a scientific administrator at the EMA, London, and served as head of pharmaceutical department at Sanofi Winthrop in Munich.

Dr Ludger Langer moves to MorphoSys from contract research organisation PRA International to take up the position of head of clinical operations and project management.

He brings almost 20 years of clinical operations and project management experience to MorphoSys prior to which he was vice president, clinical operations, Europe, Asia-Pacific and Africa at PRA.

Finally MorphoSys has also appointed Dr Steffen Heeger as head of clinical research. He was previously head of medical affairs at Merck Serono, where he also led the global clinical development team for its cancer drug Erbitux.

6th January 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics